Nasdaq GlobeNewswire

Largest, Most Popular Business School Programs Worldwide See Application Growth While Smaller Programs Experience Declines

Del

Programs in Europe, Canada, India, and East and Southeast Asia Witness Gains; U.S. Programs Suffer From Shifting Demand

RESTON, Va., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Nearly 3 in 4 (73 percent) graduate business programs with 201 or more class seats report increased application volumes this year compared to 39 percent of the smallest programs (50 or fewer class seats), according to a new application trends survey from the Graduate Management Admission Council (GMAC). The growth among the larger U.S. programs is driven by a resurgence of domestic applications, offsetting declines in international applicants.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/9e12e0d8-1e20-492d-90cd-4a7db8ee7175

Regardless of class size, a majority of programs in Europe, Canada, East and Southeast Asia, and India report growing volumes in 2017, while fewer than half the programs in the United States are growing - with the exception of part-time lockstep MBA and Master in Data Analytics programs.

"Demand for graduate business education remains strong, especially among the largest programs, which tend also to be the most well-known programs with brand recognition," said Sangeet Chowfla, GMAC president and CEO. "While non-U.S. programs are thriving, a strong economy and a disruptive political climate are likely contributing to the downward trend in application volumes among smaller U.S. programs this year."

GMAC conducted its 18th annual Application Trends Survey from early June to mid-July 2017. The survey findings are based on a record number of responses from 351 business schools and faculties located in 40 countries representing 965 graduate management programs, including MBA, non-MBA business master's, and doctoral-level programs. Participating programs received a combined total of 466,176 applications during the 2017 application cycle. Ninety-two percent of all participating programs report that the applicants this year are similarly or more academically qualified than candidates last year.

U.S. Political Climate Impacts International Application Volumes

Recent political events in the U.S. appear to have impacted application volumes from international candidates in 2017. Programs in Europe and Canada are about twice as likely to report growth in international applicants compared with the U.S. Across all program types, just 32 percent of U.S. programs report growing international application volumes in 2017 vs. 49 percent in 2016. Conversely, seventy-seven percent of Canadian programs report increases in international applications (46 percent in 2016), as well as 67 percent of European programs (65 percent in 2016). Despite the Brexit vote, about two-thirds of programs in the United Kingdom have seen international demand grow.

Overall, the 2017 report findings show that international applicants represent 57 percent of U.S. application volumes, 70 percent of Canadian volume, 89 percent of European volume, 20 percent of East and southeast Asian volume, and less than one percent of Indian volume.

Domestic candidates remain an area of strength for the larger, well known U.S. programs. Sixty-nine percent of programs with class sizes of more than 200 report growth in domestic applications, offsetting the fact that only 38 percent of programs similar in size report growth in international applications.

Women Make Gains in Applicant Pool

The results of the GMAC Application Trends Survey Report 2017 show that women are increasing their representation in the graduate business school pipeline. Today, women represent 42 percent of the total applications received by participating survey programs, up from 37 percent in 2013. Most program types have experienced an increase in the representation of women in the application pipeline. Specifically, among MBA programs women represent 39 percent of applications, up from 33 percent in 2013. More MBA programs report growth in female applicants (44 percent) compared with business master's (39 percent), whereas the growth rate is similar for men - 40 percent for MBA and 39 percent for business master's.

Additional Key Findings

  • Overall volume to the general part-time MBA program category has been stagnant or on the decline since the Great Recession. Part-time lockstep programs - in which students proceed through a classroom-based program as a group - have seen stronger application volumes than part-time self-paced programs, in which students set their own schedule in a flexible format. Among U.S. part-time MBA programs, 54 percent of lockstep programs report increased volume this year, compared with just 34 percent of self-paced programs.
  • Most graduate business programs expect to see employer sponsorship remain stable. About half (52 percent) of part-time, self-paced students are expected to receive employer support, as are 40 percent of executive MBA and 39 percent of part-time lock-step MBA students.
  • The level of experience that the applicant brings to the graduate business program has remained relatively consistent in 2017 compared with five years ago. For example, the majority of full-time MBA applicants have between three and 10 years of experience; the majority of executive MBA applicants have 10 or more years of experience; and most online MBA applicants have six or more years of experience.
  • Among business master's programs, applicants tend to have less than one year of work experience; the exception is the Master in Data Analytics candidate who tends to have more experience.

To download GMAC's Application Trends Survey Report 2017 visit: gmac.com/applicationtrends.
For supporting graphics, visit the GMAC News Center.

About GMAC: The Graduate Management Admission Council (GMAC) is a global, non-profit association of 220 leading graduate business schools. Founded in 1953, we are actively committed to advancing the art and science of admissions by convening and representing the industry and offering best-in-class products and services for schools and students. GMAC owns and administers the Graduate Management Admission Test® (GMAT®) exam, used by more than 6,500 graduate programs worldwide. Other GMAC assessments include the NMAT by GMAC(TM) exam, for entrance into graduate management programs in India and South Africa, and the Executive Assessment, specifically designed for Executive MBA programs around the world. The Council is based in the United States with offices in the United Kingdom, India, and Hong Kong. For information on assessments, study tools and services for candidates, visit www.mba.com. For information about The Council and our market intelligence, professional development opportunities and services for graduate management education, please visit www.gmac.com

MEDIA CONTACT:  
Jennifer Garfinkel; Director of Media Relations, GMAC
+1 (703) 668-9805 or jgarfinkel@gmac.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Graduate Management Admission Council via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

World Conference on Lung Cancer Monday Press Conference: Clinical Research Results and Gender Differences in Lung Cancer Survival24.9.2018 20:26Pressemelding

TORONTO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- At today’s press conference at the International Association for the Study of Lung Cancer’s (IASLC’s) 19th World Conference on Lung Cancer (WCLC), conference co-president Dr. Andrea Bezjak, M.D., FRCPC, MSc, professor in the Departments of Radiation Oncology and Health Policy, Management and Evaluation at the University of Toronto and staff radiation oncologist at Princess Margaret Cancer Centre, summarized the wide-ranging study topics presented in today’s conference, from significant clinical research findings to gender differences in lung cancer survival. IMpower132 study shows atezolizumab in combination with carboplatin and pemetrexed improves survival in Stage IV non-squamous NSCLC Recent findings from the IMpower132 study, presented by Vassiliki A. Papadimitrakopoulou, M.D., chief of the Section of Thoracic Medical Oncology at MD Anderson Cancer Center, demonstrate that the use of atezolizumab in combination with carboplatin as first-l

Bombardier CRJ Series Certified for Higher Maintenance Intervals24.9.2018 18:00Pressemelding

MONTREAL, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Bombardier Commercial Aircraft announced today that the Federal Aviation Agency (FAA) has granted approval for the maintenance intervals escalation of the CRJ700, CRJ900 and CRJ1000 aircraft. The line maintenance interval (A-check) is extended to 800 flight hours, and the heavy maintenance interval (C-check) at 8,000 flight hours. “With the longest maintenance intervals on the regional jet market, the CRJ aircraft family continues to deliver more value to operators, along with its excellent reliability and its proven outstanding operational capability”, said Charles Comtois, Head of CRJ Series Program, Bombardier Commercial Aircraft. “We are thrilled that our operators are benefitting from our continuous improvement mindset as with this evolution, the CRJ Series operators can now take advantage of 14 per cent less maintenance days, meaning more days of revenue flying.” The maintenance intervals have doubled since the launch of the CRJ aircra

Mitratech Launches Latest TeamConnect ELM Innovations at Interact24.9.2018 16:01Pressemelding

Full Integration of TAP Workflow Automation, New Business Intelligence Module and Deeper MS Office Integration Enhance Collaboration and Reporting AUSTIN, Texas, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Mitratech released the next version of TeamConnect at Interact, the company’s customer-focused annual event in Austin. The latest version of the award-winning ELM platform now includes: Full Integration with TAP Workflow Automation Business Intelligence reporting Deeper Microsoft® Office integration Today, TeamConnect integrates with TAP Workflow Automation and redefines every aspect of data analytics and reporting through the TeamConnect Business Intelligence (BI) module. With the addition of the TAP Workflow Automation Platform recently acquired in April, Mitratech’s TeamConnect platform can now bring people, processes, and information together like never before, by leveraging TAP’s easy-to-use workflow automation engine to extend TeamConnect’s reach across the entire enterprise. TAP was des

Colliers International Appoints Christopher Galvin to Its Board of Directors24.9.2018 16:00Pressemelding

TORONTO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Colliers International Group Inc. (NASDAQ and TSX: CIGI) (“Colliers”) today announced the appointment of Mr. Christopher Galvin to its Board of Directors, effective immediately. Mr. Galvin previously served as the Chairman and co-founder of Harrison Street Real Estate Capital LLC, one of the largest real estate investment firms dedicated to the education, healthcare and storage sectors. Colliers acquired a 75% interest in Harrison Street earlier this year. Mr. Galvin presently serves as Chairman or board member of Uniquesoft, LLC, Velocidata, evolve24, Three Ocean Partners and MCR-Aerodyne, Inc. Additionally, Mr. Galvin is a member of the Executive Committee of Northwestern University’s Board of Trustees, and the Boards of Trustees of the American Enterprise Institute, the Legion D’honneur, and Tsinghua University School of Economics Management Advisory Council, among others. Mr. Galvin has previously served in a variety of executive leadersh

Seclore Offers the First Open Data-Centric Security Platform24.9.2018 15:00Pressemelding

Easily leverage best-of-breed data protection solutions and existing Enterprise systems for an automation-first approach to data protection and tracking MILPITAS, Calif., Sept. 24, 2018 (GLOBE NEWSWIRE) -- Seclore, providers of the industry’s first browser-based Rights Management solution, today announced the release of Seclore’s Data-Centric Security Platform (DCSP). A first-of-its kind platform, it is designed to give customers an open, integrated and automated Data-Centric Security approach to discover, identify, protect and track sensitive data. The automation and agility of the platform enables organizations to remove the limitations of point solutions while increasing the security of sensitive data. At the core of the Seclore DCSP, is the Seclore Unified Policy Manager, the central engine for orchestrating policy management, identity federation, and usage data consolidation. Learn more about the Seclore Data-Centric Security Platform “As data grows exponentially and is stored and

XBiotech Announces Completion of U.S. Enrollment in Phase 2 Multicenter Study Evaluating Bermekimab in Patients with Hidradenitis Suppurativa24.9.2018 14:30Pressemelding

AUSTIN, Texas, Sept. 24, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today that it had completed enrollment in the U.S. for its Phase 2, open label clinical study evaluating subcutaneous administration of bermekimab in patients with moderate to severe Hidradenitis Suppurativa (HS). Enrollment has exceeded the planned limit for the study in just over two months, significantly outpacing expectations. XBiotech plans to accept a limited number of additional patients in Europe prior to study completion. John Simard, Chairman & CEO of XBiotech, commented, “We are very pleased by the enrollment rate we have seen in this study. Patient availability has been well beyond what was predicted. I believe this speaks to the need for new treatment options for this debilitating disease. I want to thank all of the patients and clinical sites for their ongoing participation in this study.” The phase 2 study involves a 13-week treatment regimen. Two groups of patients are being treated

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom